Trivedi Rupal H, Apple David J, Pandey Suresh K, Werner Liliana, Izak Andrea M, Vasavada Abhay R, Ram Jagat
Center for Research on Ocular Therapeutics and Biodevices, Storm Eye Institute, Medical University of South Carolina, South Carolina, USA.
Indian J Ophthalmol. 2003 Sep;51(3):211-6.
Cataract surgery with intraocular lens (IOL) implantation has become the most common and most successful of all operations in medicine. Sir Harold Ridley's first cataract extraction with implantation of an IOL marked the beginning of a major change in the practice of ophthalmology. Millions of patients worldwide have benefited from Sir Ridley's invention, and are likely to continue to derive benefit from this device. However, the development of the IOL was not without its share of ups and downs. Sir Harold Ridley, the inventor of IOL, died at the age of 94, on 25 May 2001, and ophthalmology lost one of its greatest and most influential practitioners. We are happy that he lived to enjoy the fruits of his labour--to see the amazing improvements and the expansive growth that evolved in the cataract-IOL technique, from early and unsatisfactory operations in previous decades, to the superb results attainable today. The invention of the IOL has not been just the addition of one new form of treatment, but rather, Sir Harold's tiny disc-shaped sliver of plastic has changed the world so that our patients may better see it. This article presents a brief biographical sketch of Sir Harold and lists his major inventions and contributions to ophthalmology.
人工晶状体（IOL）植入的白内障手术已成为医学领域所有手术中最常见且最成功的手术。哈罗德·里德利爵士首次进行的白内障摘除并植入人工晶状体手术标志着眼科实践发生重大变革的开端。全球数百万患者受益于里德利爵士的发明，并且可能会继续从这一器械中获益。然而，人工晶状体的发展并非一帆风顺。人工晶状体的发明者哈罗德·里德利爵士于2001年5月25日辞世，享年94岁，眼科界失去了一位最伟大且最具影响力的从业者。我们很高兴他能活到享受自己的劳动成果——目睹白内障-人工晶状体技术从几十年前早期不尽人意的手术发展到如今可实现的卓越效果所带来的惊人进步和广泛发展。人工晶状体的发明不仅仅是增添了一种新的治疗方式，相反，哈罗德爵士那小小的圆盘状塑料薄片改变了世界，让我们的患者能更好地看清这个世界。本文简要介绍了哈罗德爵士的生平，并列举了他的主要发明以及对眼科的贡献。
